SAM.gov75F40126Q22123
Open
Illumina MiSeq i100 System
- Response deadline
- May 22, 2026 Closed
- Date posted
- May 15, 2026
- Source
- Open notice
Description
This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government�s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.
Classifications
Documents
No documents posted for this opportunity.
Similar contracts
- Notice of Intent: Zeiss LSM 800 Microscope UpgradesMarylandDue Aug 28, 2026
- Notice of Intent: Vega camera for BrainSight systemMarylandDue Aug 28, 2026
- Notice of Intent to Sole Source - Particle InstrumentsGeorgiaDue Aug 26, 2026
- Monochromator for Empyrean XRDDue Aug 26, 2026
- INTENT TO AWARD TO A SINGLE SOURCE - OPENTRONS ROBOTMarylandDue Sep 8, 2026
- ZEISS Axiovert 5 TL/FL Microscope with Phase Contrast at 5x, DIC at 10x-100x, and Colibri 3 with 4-Channel FluorescenceMarylandDue Sep 2, 2026